NEW YORK--(BUSINESS WIRE)--The Law Offices of Vincent Wong are investigating the Board of Directors of Bioverativ Inc. (NASDAQGS: BIVV) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Sanofi. Under the terms of the deal, Bioverativ shareholders will receive $105 for each Bioverativ share they own.
The investigation concerns whether the Bioverativ Board of Directors breached their fiduciary duties to Bioverativ stockholders by failing to adequately shop the Company before entering into this transaction and whether Sanofi is underpaying for Bioverativ shares, thus unlawfully harming Bioverativ stockholders.
If you own common stock in Bioverativ and wish to obtain additional information, please contact Vincent Wong, Esq. either via email firstname.lastname@example.org, by telephone at 212.425.1140, or http://docs.wongesq.com/BIVV-Info-Request-Form-1790.
Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.